Peru vs Viet Nam: HIV/AIDS deaths averted by antiretroviral therapy
Peru
6,549 deaths
in 2024
Viet Nam
8,037 deaths
in 2024
Peru rank
30th
Viet Nam rank
28th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Peru
- Viet Nam
How they compare
Viet Nam currently reports 8,037 deaths against 6,549 deaths in Peru, a difference of 1,488 deaths.
That makes Viet Nam's figure about 1.2 times Peru's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Viet Nam ahead.
Peru ranks 30th and Viet Nam ranks 28th of 157 countries.
Viet Nam has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Peru | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 908.88 deaths | 1,430 deaths | 520.77 deaths | Viet Nam |
| 2010s | 4,028 deaths | 8,644 deaths | 4,615 deaths | Viet Nam |
| 2020s | 6,039 deaths | 8,576 deaths | 2,537 deaths | Viet Nam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Peru or Viet Nam?
- Viet Nam, at 8,037 deaths against 6,549 deaths in Peru as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Peru and Viet Nam?
- 1,488 deaths, with Viet Nam ahead.
- How many years of comparable data are there for Peru and Viet Nam?
- 35 years are reported by both, from 1990 to 2024.
- How do Peru and Viet Nam rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Peru ranks 30th and Viet Nam ranks 28th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.